BridgeMD
New treatment option for Healthy Adult
Official title Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
ClinicalTrials.gov ID: NCT07428889
What this study is testing
- What it's testing
- The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Males and females, ≥45 to ≤65 years of age
- BMI ≥18.5 and \<30.0 kg/m2
- Ambulatory and currently free of injury or other physical impairment that hinders mobility.
- Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer).
- Willingness to maintain current skin care regimen and avoid any skin-related medical procedures.
You likely can't join if
- Is currently following, or planning to be on, a weight loss regimen.
- Weight loss or gain \>4.5 kg.
- History of gastrointestinal surgery for weight reducing purposes.
- History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator.
- History of neurologic disorder that could produce cognitive deterioration.
- History of bouts of delirium, confusion, repeated minor head injury or a single injury.
See the full eligibility criteria
- Males and females, ≥45 to ≤65 years of age
- BMI ≥18.5 and \<30.0 kg/m2
- Ambulatory and currently free of injury or other physical impairment that hinders mobility.
- Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer).
- Willingness to maintain current skin care regimen and avoid any skin-related medical procedures.
- Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information to...
- Is currently following, or planning to be on, a weight loss regimen.
- Weight loss or gain \>4.5 kg.
- History of gastrointestinal surgery for weight reducing purposes.
- History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator.
- History of neurologic disorder that could produce cognitive deterioration.
- History of bouts of delirium, confusion, repeated minor head injury or a single injury.
- History of unconventional sleep patterns or a diagnosed sleep disorder.
- History of any infective or inflammatory brain disease.
- Use of tobacco/nicotine products.
- Use of hemp/marijuana products.
- Unstable use of any prescription medication.
- Unstable use (initiation or change in dose) of hormonal contraceptives or therapy.
- Use of any dietary supplements (orally or infused), other than a conventional once daily multi-vitamin.
- Use of medication(s) or dietary supplement(s) known to affect absorption.
- Recent history of or strong potential for alcohol or substance abuse.
- Exposed to any non-registered drug product.
- A score of \<7 on the Vein Access Scale Assessment.
- History or presence, on the basis of the medical history or screening labs, of clinically important cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, gastrointestinal, biliary, pancreatic, or...
- Uncontrolled hypertension.
- Known allergy to any ingredients contained in the study product.
- Any signs or symptoms of active infection of clinical relevance.
- History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
- History of any major trauma or major surgical event.
- Female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential with unstable use of sex hormones for contraception.
- An employee or representative who has a financial interest in Sponsor organization.
The study team makes the final eligibility decision.
Where it's taking place
- Addison, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Addison, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.